Neuropathologic findings of dementia with lewy bodies (DLB) in a population-based Vantaa 85+ study.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 19625740)

Published in J Alzheimers Dis on January 01, 2009

Authors

Minna Oinas1, Tuomo Polvikoski, Raimo Sulkava, Liisa Myllykangas, Kati Juva, Irma-Leena Notkola, Sari Rastas, Leena Niinistö, Hannu Kalimo, Anders Paetau

Author Affiliations

1: Department of Pathology, University of Helsinki, and Helsinki University Central Hospital, P.O. Box 21 (Haartmaninkatu 3), FI-00014 Helsinki, Finland. minna.oinas@helsinki.fi

Articles by these authors

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron (2011) 18.73

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet (2002) 8.19

Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol (2010) 4.19

Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging (2011) 3.27

Muscle injuries: biology and treatment. Am J Sports Med (2005) 3.15

Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain (2012) 2.64

The significance of latissimus dorsi flap innervation in delayed breast reconstruction: a prospective randomized study-magnetic resonance imaging and histologic findings. Plast Reconstr Surg (2011) 2.61

Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke (2004) 2.53

FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol (2011) 2.36

Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet (2005) 2.23

Association between blood pressure and survival over 9 years in a general population aged 85 and older. J Am Geriatr Soc (2006) 2.21

Notch signaling regulates platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells. Circ Res (2008) 2.15

Retracted VMA21 deficiency causes an autophagic myopathy by compromising V-ATPase activity and lysosomal acidification. Cell (2009) 2.11

Saccular intracranial aneurysm: pathology and mechanisms. Acta Neuropathol (2012) 2.09

The gene disrupted in Marinesco-Sjögren syndrome encodes SIL1, an HSPA5 cochaperone. Nat Genet (2005) 2.05

Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice. Proc Natl Acad Sci U S A (2005) 1.88

Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain (2007) 1.85

Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet (2011) 1.80

Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo. J Neurosci (2007) 1.75

Self-reported sleep duration and cognitive functioning in the general population. J Sleep Res (2009) 1.71

Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle. J Cell Sci (2003) 1.71

Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest (2006) 1.69

Education, the brain and dementia: neuroprotection or compensation? Brain (2010) 1.68

Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci (2004) 1.63

Muscle injuries: optimising recovery. Best Pract Res Clin Rheumatol (2007) 1.62

Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol Brain (2009) 1.62

Effects of dementia on perceived daily pain in home-dwelling elderly people: a population-based study. Age Ageing (2004) 1.56

ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. Am J Surg Pathol (2011) 1.55

The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice. Neurobiol Aging (2005) 1.53

Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas. Mol Cancer Res (2006) 1.51

Increased incidence of hip fractures. A population based-study in Finland. Bone (2006) 1.50

Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study. Eur J Clin Pharmacol (2006) 1.49

Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf (2011) 1.47

Distal myopathy caused by homozygous missense mutations in the nebulin gene. Brain (2007) 1.46

Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging (2009) 1.45

Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy. Hum Mol Genet (2012) 1.45

Bedside diagnosis of rippling muscle disease in CAV3 p.A46T mutation carriers. Muscle Nerve (2010) 1.43

Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome. J Neuropathol Exp Neurol (2007) 1.42

VMA21 deficiency prevents vacuolar ATPase assembly and causes autophagic vacuolar myopathy. Acta Neuropathol (2013) 1.34

Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging (2009) 1.31

Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med (2008) 1.30

Mitochondrial DNA sequence variation and mutation rate in patients with CADASIL. Neurogenetics (2006) 1.30

Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke (2009) 1.30

Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet (2008) 1.29

Physical functioning in elderly Europeans: 10 year changes in the north and south: the HALE project. J Epidemiol Community Health (2005) 1.28

Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Hum Mol Genet (2011) 1.26

Cdk5 regulates the organization of Nestin and its association with p35. Mol Cell Biol (2003) 1.24

Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain (2009) 1.23

Identification of low molecular weight pyroglutamate A{beta} oligomers in Alzheimer disease: a novel tool for therapy and diagnosis. J Biol Chem (2010) 1.22

Fibrosis and stenosis of the long penetrating cerebral arteries: the cause of the white matter pathology in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Brain Pathol (2004) 1.22

Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases. J Neural Transm (Vienna) (2009) 1.22

Delaying decline in pulmonary function with physical activity: a 25-year follow-up. Am J Respir Crit Care Med (2003) 1.21

Intensive geriatric rehabilitation of hip fracture patients: a randomized, controlled trial. Acta Orthop Scand (2002) 1.19

Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome. Brain (2008) 1.15

Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. J Clin Psychiatry (2008) 1.13

Tracking of systolic blood pressure during childhood: a 15-year follow-up population-based family study in eastern Finland. J Hypertens (2002) 1.12

Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology (2004) 1.11

Complement activation associates with saccular cerebral artery aneurysm wall degeneration and rupture. Neurosurgery (2006) 1.11

B-type natriuretic peptide as a predictor of declining cognitive function and dementia--a cohort study of an elderly general population with a 5-year follow-up. Ann Med (2010) 1.09

Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease. Proc Natl Acad Sci U S A (2011) 1.08

Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography. Cancer (2002) 1.07

Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population. Neurobiol Aging (2012) 1.07

Combined hearing and visual impairment and depression in a population aged 75 years and older. Int J Geriatr Psychiatry (2002) 1.06

CADASIL and CARASIL. Brain Pathol (2014) 1.05

Validity of the Finnish Prescription Register for measuring psychotropic drug exposures among elderly finns: a population-based intervention study. Drugs Aging (2010) 1.05

Recessive twinkle mutations cause severe epileptic encephalopathy. Brain (2009) 1.04

Concomitant use of analgesics and psychotropics in home-dwelling elderly people-Kuopio 75 + study. Br J Clin Pharmacol (2005) 1.04

Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas. Cancer (2003) 1.03

The non-use of hearing aids in people aged 75 years and over in the city of Kuopio in Finland. Eur Arch Otorhinolaryngol (2004) 1.03

Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein MRPL44 to underlie mitochondrial infantile cardiomyopathy. J Med Genet (2013) 1.02

A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice. Neurobiol Aging (2008) 1.02

Atrial fibrillation, stroke, and cognition: a longitudinal population-based study of people aged 85 and older. Stroke (2007) 1.02

A randomized controlled trial of rehabilitation after hospitalization in frail older women: effects on strength, balance and mobility. Scand J Med Sci Sports (2002) 1.01

Growth factor receptor expression and remodeling of saccular cerebral artery aneurysm walls: implications for biological therapy preventing rupture. Neurosurgery (2006) 1.01

Community prevalence of alcohol use and concomitant use of medication--a source of possible risk in the elderly aged 75 and older? Int J Geriatr Psychiatry (2005) 1.00

Deficiency of the E3 ubiquitin ligase TRIM2 in early-onset axonal neuropathy. Hum Mol Genet (2013) 1.00

Adverse drug effects in elderly people -- a disparity between clinical examination and adverse effects self-reported by the patient. Eur J Clin Pharmacol (2007) 0.99

Drug Burden Index associated with function in community-dwelling older people in Finland: a cross-sectional study. Ann Med (2011) 0.99